Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Aimovig

PharmaCompass

01

Brand Name : Aimovig

Erenumab

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Aimovig

arrow
euroPLX 86 Munich
Not Confirmed

Erenumab

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 378

2019 Revenue in Millions : 306

Growth (%) : 24

blank

02

Brand Name : Aimovig

Erenumab

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Aimovig

arrow
euroPLX 86 Munich
Not Confirmed

Erenumab

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 164

2019 Revenue in Millions : 103

Growth (%) : 59

blank

03

Brand Name : Aimovig

Erenumab

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Aimovig

arrow
euroPLX 86 Munich
Not Confirmed

Erenumab

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 317

2020 Revenue in Millions : 378

Growth (%) : -16

blank

04

Brand Name : Aimovig

Erenumab

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Aimovig

arrow
euroPLX 86 Munich
Not Confirmed

Erenumab

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 215

2020 Revenue in Millions : 164

Growth (%) : 31

blank

05

Brand Name : Aimovig

Erenumab

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Aimovig

arrow
euroPLX 86 Munich
Not Confirmed

Erenumab

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 414

2021 Revenue in Millions : 317

Growth (%) : 31

blank

06

Brand Name : Aimovig

Erenumab

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Aimovig

arrow
euroPLX 86 Munich
Not Confirmed

Erenumab

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 218

2021 Revenue in Millions : 215

Growth (%) : 1

blank

07

Brand Name : Aimovig

Erenumab

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Aimovig

arrow
euroPLX 86 Munich
Not Confirmed

Erenumab

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 266

2022 Revenue in Millions : 218

Growth (%) : 22

blank

08

Brand Name : Aimovig

Erenumab

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Aimovig

arrow
euroPLX 86 Munich
Not Confirmed

Erenumab

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 119

2017 Revenue in Millions : 0

Growth (%) : New Launch

blank

09

Brand Name : Aimovig

Erenumab

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Aimovig

arrow
euroPLX 86 Munich
Not Confirmed

Erenumab

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 306

2018 Revenue in Millions : 119

Growth (%) : 157

blank

10

Brand Name : Aimovig

Erenumab

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Aimovig

arrow
euroPLX 86 Munich
Not Confirmed

Erenumab

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 103

2018 Revenue in Millions : 8

Growth (%) : 1,188

blank